Company / Net Debt per Share
ANI Pharmaceuticals, Inc. Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$0.30
FY2025
5-year range
$0.30 / $14.78
FY2021-FY2025
Trend
-97.1%
vs FY2024
Sector context
#46 of 82
Health Care
What the data says
At $0.30, ANI Pharmaceuticals, Inc.'s net debt per share ranks #37 of 82 in the Health Care sector. Net Debt per Share has fluctuated over the past 10 years, ranging from $0.30 in FY2025 to $14.78 in FY2021.
Based on SEC 10-K filings.
0.30 in FY2025 with a 5-year CAGR of -53.6%.
Improved from $3.50 to $0.30 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -72.7%
- 5-Year CAGR
- -53.6%
- 10-Year CAGR
- -
Sector benchmark
#37 of 82 in Health CareTop 44% of 82This company $0.30 Sector average $13.70
▼
-97.8% below sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 97.1% year-over-year.
- Ranks #46 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.30 | -97.1% |
| FY2024 | $10.10 | +188.5% |
| FY2023 | $3.50 | -76.0% |
| FY2022 | $14.60 | -1.2% |
| FY2021 | $14.78 | +7.5% |
| FY2020 | $13.76 | +40.0% |
| FY2019 | $9.83 | +376.3% |
| FY2018 | $2.06 | -75.4% |
| FY2017 | $8.40 | +4.2% |
| FY2016 | $8.06 | -100.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026